關於Roche CIT
A platform provides latest cancer immunotherapy scientific information.
CIT (Cancer ImmunoTherapy) is an application developed by Roche. It contains update cancer immunotherapy scientific information. This platform is intended for the exclusive use by Healthcare Professionals in Taiwan.
It is designed to unsolicited provide scientific updated related to cancer immunotherapy and provide clinical supporting tool related to cancer immunotherapy treatment. It features personalized and interactive design to
facilitate the scientific exchange.
最新版本1.0.8的更新日誌
Last updated on 2021年09月21日
New Functionality
Roche CIT歷史版本
Roche CIT 1.0.8
22.7 MB2021年09月21日
Roche CIT 1.0.7
22.7 MB2020年03月18日
Roche CIT 1.0.6
22.7 MB2020年03月11日
Roche CIT 1.0.5
22.8 MB2019年12月22日